コネチカット州における過体重の臨床試験
コネチカット州内の拠点で、過体重に関する16件の研究が参加者を募集しています。
コネチカット州内の都市
公式研究テキスト（英語）
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Yale University School of Medicine, New Haven
- Chase Medical Research, LLC, Waterbury
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Yale School of Medicine - Yale Diabetes Center (YDC)) Trials, New Haven
- Stamford Therapeutics Consortium, Stamford
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Chase Medical Research, LLC, Waterbury
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07321886A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- New England Research Associates, LLC, Bridgeport
- Yale University School of Medicine, New Haven
- Chase Medical Research, LLC, Waterbury
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Stamford Therapeutics Consortium, Stamford
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- New England Research Associates, LLC, Bridgeport
- CMR of Greater New Haven, LLC, Hamden
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Yale University, New Haven
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Waterbury
被験者募集中第3相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Stamford Therapeutics Consortium, Stamford
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Bridgeport
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284875Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Chase Medical Research LLC, Waterbury
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Stamford
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Chase Medical Research LLC, Waterbury
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT07509307Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
- Yale University, New Haven
被験者募集中健康なボランティア歓迎
40歳以上 · 全性別 · 2026/06/17更新 · NCT07376655Craving Network Neurofeedback
- Yale MRRC Anlyan Center, New Haven
被験者募集中健康なボランティア歓迎
18歳〜60歳 · 全性別 · 2025/12/03更新 · NCT06426693ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。